Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Shares Outstanding (Weighted Average): 2013-2025

Historic Shares Outstanding (Weighted Average) for Phibro Animal Health (PAHC) over the last 13 years, with Jun 2025 value amounting to $40.5 million.

  • Phibro Animal Health's Shares Outstanding (Weighted Average) rose 0.07% to $40.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year increase of 0.07%. This contributed to the annual value of $40.5 million for FY2025, which is 0.07% up from last year.
  • Latest data reveals that Phibro Animal Health reported Shares Outstanding (Weighted Average) of $40.5 million as of FY2025, which was up 0.07% from $40.5 million recorded in FY2024.
  • Phibro Animal Health's Shares Outstanding (Weighted Average)'s 5-year high stood at $40.5 million during FY2025, with a 5-year trough of $40.5 million in FY2021.
  • In the last 3 years, Phibro Animal Health's Shares Outstanding (Weighted Average) had a median value of $40.5 million in 2024 and averaged $40.5 million.
  • Data for Phibro Animal Health's Shares Outstanding (Weighted Average) shows a peak YoY rose of 0.12% (in 2021) over the last 5 years.
  • Over the past 5 years, Phibro Animal Health's Shares Outstanding (Weighted Average) (Yearly) stood at $40.5 million in 2021, then remained steady at $40.5 million in 2022, then remained steady at $40.5 million in 2023, then remained steady at $40.5 million in 2024, then increased by 0.07% to $40.5 million in 2025.